Blocking HIV-1 Vif Restores a Natural Mechanism of Intracellular Antiviral Defense

E-ISSN： 1875-5917|4|4|257-263

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.4, 2004-12, pp. : 257-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Vif protein of Human Immunodeficiency Virus Type 1 (HIV-1): Enigmas and Solutions [General Articles]

Current Medicinal Chemistry, Vol. 11, Iss. 2, 2004-01 ,pp. : 221-231

Bentham Science Publishers

Access to resources Recommend Favorite

Blocking HIV-1 Replication by Targeting the Tat-Hijacked Transcriptional Machinery

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1860-1879

Bentham Science Publishers

Access to resources Recommend Favorite

Etravirine: potent antiviral activity in HIV-1 with NNRTI resistance

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

HIV-1 RT Nonnucleoside Inhibitors and Their Interaction with RT for Antiviral Drug Development

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 391-413

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Cell-to-Cell Transmission and Antiviral Strategies: An Overview

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 65-75

Bentham Science Publishers

Access to resources Recommend Favorite